Drug name - Glumetza
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7780987 | SANTARUS INC | Controlled release dosage forms |
Mar, 2025
(2 years from now) | |
| EP1476138B1 | SANTARUS INC | Modified Release Formulations Of At Least One Form Of Tramadol |
Feb, 2023
(4 months from now) | |
| EP1476139A1 | SANTARUS INC | Controlled Release Dosage Forms |
Feb, 2023
(4 months from now) | |
| EP1476138A2 | SANTARUS INC | Modified Release Formulations Of At Least One Form Of Tramadol |
Feb, 2023
(4 months from now) | |
| EP1476138B8 | SANTARUS INC | Modified Release Formulations Of At Least One Form Of Tramadol |
Feb, 2023
(4 months from now) | |
| EP1476138A4 | SANTARUS INC | Modified Release Formulations Of At Least One Form Of Tramadol |
Feb, 2023
(4 months from now) | |
| EP1476139B1 | SANTARUS INC | Controlled Release Dosage Forms |
Feb, 2023
(4 months from now) | |
| EP1476139A4 | SANTARUS INC | Controlled Release Dosage Forms |
Feb, 2023
(4 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8323692 | SANTARUS INC | Controlled release dosage forms |
Mar, 2023
(5 months from now) | |
Drugs and Companies using METFORMIN HYDROCHLORIDE ingredient
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1GM | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 500MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.